Memorial Sloan Kettering Cancer Center 9th Annual MSK Symposium on Lymphoma 2025

• Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees
• Sample video: contact me for sample video
• Information:

Specialties

Specialties – Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology

Overview

This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.

We look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.

Objectives

At the conclusion of this symposium, attendees will be able to:

Describe recent advances in lymphoma classification

Describe new agents mode of actions, efficacy, side effects

Discuss options and recommendations for patients in the relapse refractory setting

Provide adequate information to help shared decision with patients regarding their treatment

• Topics:

Advances in Biology.mp4

Advances in Biology.pdf

Advancing Therapeutic Options in the Relapse Setting.mp4

Advancing Therapeutic Options in the Relapse Setting.pdf

B-Cell Dynamics in the Germinal Center.mp4

B-Cell Dynamics in the Germinal Center.pdf

Biology of Hodgkin Lymphoma.mp4

Biology of Hodgkin Lymphoma.pdf

CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.mp4

CAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.pdf

Cellular Therapies for Treating Mantle Cell Lymphoma.mp4

Cellular Therapies for Treating Mantle Cell Lymphoma.pdf

Epidemiology and Outcomes of Lymphoma.mp4

Epidemiology and Outcomes of Lymphoma.pdf

Germinal Center Biology.pdf

Histologic Transformation of Follicular Lymphoma.mp4

Histologic Transformation of Follicular Lymphoma.pdf

Lessons and Challenges.mp4

Lessons and Challenges.pdf

Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.mp4

Lymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.pdf

Lymphoma2025_Brochure.pdf

Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.mp4

Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.pdf

Management of Older Patients.mp4

Management of Older Patients.pdf

Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.mp4

Mantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.pdf

New Antibodies Engaging Immune Cells.mp4

New Antibodies Engaging Immune Cells.pdf

New Drugs on the Horizon for Follicular Lymphoma.mp4

New Drugs on the Horizon for Follicular Lymphoma.pdf

Notch and Marginal Zone Biology.mp4

Notch and Marginal Zone Biology.pdf

Optimizing Patient Selection in 2025.mp4

Optimizing Patient Selection in 2025.pdf

Panel Discussion- Advances in Therapeutic Strategies for Mantle Cell Lymphoma.mp4

Panel Discussion- Aggressive B-Cell Lymphoma & Car T-Cell Therapies in Large B-Cell Lymphoma.mp4

Panel Discussion- Aggressive B-Cell Lymphoma- Addressing Remaining Gaps on the Path to a Definitive Cure.mp4

Panel Discussion- Current Challenges in the Management of Patients with Follicular Lymphoma.mp4

Panel Discussion- Empowering APPs and Nurses.mp4

Panel Discussion- Hodgkin Lymphoma.mp4

Panel Discussion- Improving Outcomes of Patients with T-Cell Lymphoma.mp4

Panel Discussion- The Dark Side of B-Cells.mp4

Progress in Large B-Cell Lymphoma Management.mp4

Progress in Large B-Cell Lymphoma Management.pdf

Radiation Therapy and CAR T.mp4

Recent Insights Into Mantle Cell Lymphoma Biology.mp4

Recent Insights Into Mantle Cell Lymphoma Biology.pdf

Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.mp4

Research Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.pdf

Single Cell Analysis of B-Cell Lymphoma.mp4

Single Cell Analysis of B-Cell Lymphoma.pdf

Treatment Initiation Versus Active Surveillance.mp4

Treatment Initiation Versus Active Surveillance.pdf

Update on Burkitt Lymphoma.mp4

Update on Burkitt Lymphoma.pdf

Update on Primary Mediastinal B-Cell Lymphoma.mp4

Update on Primary Mediastinal B-Cell Lymphoma.pdf